213 related articles for article (PubMed ID: 36111785)
1. 7-Dehydrocholesterol-derived oxysterols cause neurogenic defects in Smith-Lemli-Opitz syndrome.
Tomita H; Hines KM; Herron JM; Li A; Baggett DW; Xu L
Elife; 2022 Sep; 11():. PubMed ID: 36111785
[TBL] [Abstract][Full Text] [Related]
2. Antioxidant supplementation ameliorates molecular deficits in Smith-Lemli-Opitz syndrome.
Korade Z; Xu L; Harrison FE; Ahsen R; Hart SE; Folkes OM; Mirnics K; Porter NA
Biol Psychiatry; 2014 Feb; 75(3):215-22. PubMed ID: 23896203
[TBL] [Abstract][Full Text] [Related]
3. An oxysterol biomarker for 7-dehydrocholesterol oxidation in cell/mouse models for Smith-Lemli-Opitz syndrome.
Xu L; Korade Z; Rosado JDA; Liu W; Lamberson CR; Porter NA
J Lipid Res; 2011 Jun; 52(6):1222-1233. PubMed ID: 21402677
[TBL] [Abstract][Full Text] [Related]
4. 7-Dehydrocholesterol-derived oxysterols and retinal degeneration in a rat model of Smith-Lemli-Opitz syndrome.
Xu L; Sheflin LG; Porter NA; Fliesler SJ
Biochim Biophys Acta; 2012 Jun; 1821(6):877-83. PubMed ID: 22425966
[TBL] [Abstract][Full Text] [Related]
5. Sterols and oxysterols in plasma from Smith-Lemli-Opitz syndrome patients.
Griffiths WJ; Abdel-Khalik J; Crick PJ; Ogundare M; Shackleton CH; Tuschl K; Kwok MK; Bigger BW; Morris AA; Honda A; Xu L; Porter NA; Björkhem I; Clayton PT; Wang Y
J Steroid Biochem Mol Biol; 2017 May; 169():77-87. PubMed ID: 26976653
[TBL] [Abstract][Full Text] [Related]
6. DHCEO accumulation is a critical mediator of pathophysiology in a Smith-Lemli-Opitz syndrome model.
Xu L; Mirnics K; Bowman AB; Liu W; Da J; Porter NA; Korade Z
Neurobiol Dis; 2012 Mar; 45(3):923-9. PubMed ID: 22182693
[TBL] [Abstract][Full Text] [Related]
7. Novel oxysterols observed in tissues and fluids of AY9944-treated rats: a model for Smith-Lemli-Opitz syndrome.
Xu L; Liu W; Sheflin LG; Fliesler SJ; Porter NA
J Lipid Res; 2011 Oct; 52(10):1810-20. PubMed ID: 21817059
[TBL] [Abstract][Full Text] [Related]
8. Lipid biomarkers of oxidative stress in a genetic mouse model of Smith-Lemli-Opitz syndrome.
Korade Z; Xu L; Mirnics K; Porter NA
J Inherit Metab Dis; 2013 Jan; 36(1):113-22. PubMed ID: 22718275
[TBL] [Abstract][Full Text] [Related]
9. Biological activities of 7-dehydrocholesterol-derived oxysterols: implications for Smith-Lemli-Opitz syndrome.
Korade Z; Xu L; Shelton R; Porter NA
J Lipid Res; 2010 Nov; 51(11):3259-69. PubMed ID: 20702862
[TBL] [Abstract][Full Text] [Related]
10. Oxidative stress, serotonergic changes and decreased ultrasonic vocalizations in a mouse model of Smith-Lemli-Opitz syndrome.
Sharif NF; Korade Z; Porter NA; Harrison FE
Genes Brain Behav; 2017 Jul; 16(6):619-626. PubMed ID: 28220990
[TBL] [Abstract][Full Text] [Related]
11. Development and characterization of a hypomorphic Smith-Lemli-Opitz syndrome mouse model and efficacy of simvastatin therapy.
Correa-Cerro LS; Wassif CA; Kratz L; Miller GF; Munasinghe JP; Grinberg A; Fliesler SJ; Porter FD
Hum Mol Genet; 2006 Mar; 15(6):839-51. PubMed ID: 16446309
[TBL] [Abstract][Full Text] [Related]
12. 3beta-hydroxysterol Delta7-reductase and the Smith-Lemli-Opitz syndrome.
Correa-Cerro LS; Porter FD
Mol Genet Metab; 2005 Feb; 84(2):112-26. PubMed ID: 15670717
[TBL] [Abstract][Full Text] [Related]
13. An efficient synthesis of 4α- and 4β-hydroxy- 7-dehydrocholesterol, biomarkers for patients with and animal models of the Smith-Lemli-Opitz syndrome.
Kawamoto H; Ohmori Y; Maekawa M; Shimada M; Mano N; Iida T
Chem Phys Lipids; 2013; 175-176():73-8. PubMed ID: 23920082
[TBL] [Abstract][Full Text] [Related]
14. 7-Dehydrocholesterol-dependent proteolysis of HMG-CoA reductase suppresses sterol biosynthesis in a mouse model of Smith-Lemli-Opitz/RSH syndrome.
Fitzky BU; Moebius FF; Asaoka H; Waage-Baudet H; Xu L; Xu G; Maeda N; Kluckman K; Hiller S; Yu H; Batta AK; Shefer S; Chen T; Salen G; Sulik K; Simoni RD; Ness GC; Glossmann H; Patel SB; Tint GS
J Clin Invest; 2001 Sep; 108(6):905-15. PubMed ID: 11560960
[TBL] [Abstract][Full Text] [Related]
15. 7-dehydrocholesterol efficiently supports Ret signaling in a mouse model of Smith-Opitz-Lemli syndrome.
Gou-Fàbregas M; Macià A; Anerillas C; Vaquero M; Jové M; Jain S; Ribera J; Encinas M
Sci Rep; 2016 Jun; 6():28534. PubMed ID: 27334845
[TBL] [Abstract][Full Text] [Related]
16. Analysis by liquid chromatography-mass spectrometry of sterols and oxysterols in brain of the newborn Dhcr7(Δ3-5/T93M) mouse: a model of Smith-Lemli-Opitz syndrome.
Meljon A; Watson GL; Wang Y; Shackleton CH; Griffiths WJ
Biochem Pharmacol; 2013 Jul; 86(1):43-55. PubMed ID: 23500538
[TBL] [Abstract][Full Text] [Related]
17. Modeling Smith-Lemli-Opitz syndrome with induced pluripotent stem cells reveals a causal role for Wnt/β-catenin defects in neuronal cholesterol synthesis phenotypes.
Francis KR; Ton AN; Xin Y; O'Halloran PE; Wassif CA; Malik N; Williams IM; Cluzeau CV; Trivedi NS; Pavan WJ; Cho W; Westphal H; Porter FD
Nat Med; 2016 Apr; 22(4):388-96. PubMed ID: 26998835
[TBL] [Abstract][Full Text] [Related]
18. Discordant phenotype and sterol biochemistry in Smith-Lemli-Opitz syndrome.
Koo G; Conley SK; Wassif CA; Porter FD
Am J Med Genet A; 2010 Aug; 152A(8):2094-8. PubMed ID: 20635399
[TBL] [Abstract][Full Text] [Related]
19. Oxysterols and Retinal Degeneration in a Rat Model of Smith-Lemli-Opitz Syndrome: Implications for an Improved Therapeutic Intervention.
Fliesler SJ; Xu L
Molecules; 2018 Oct; 23(10):. PubMed ID: 30360379
[TBL] [Abstract][Full Text] [Related]
20. Smith-Lemli-Opitz syndrome: pathogenesis, diagnosis and management.
Porter FD
Eur J Hum Genet; 2008 May; 16(5):535-41. PubMed ID: 18285838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
